ER-β expression in large bowel adenomas: Implications in colon carcinogenesis

BackgroundA pivotal role of oestrogen receptor-beta has been suggested in colon carcinogenesis in humans. However, few data are available on oestrogen receptor-beta in colorectal pre-cancerous lesions.AimIn the present study, we evaluated oestrogen receptor-beta expression and its possible correlation with proliferative activity and apoptosis in colorectal adenomas and normal colon tissue.Patients/methodsAdenomatous tissue from 25 patients with colonic polyps, and normal tissue from 25 controls were used. Oestrogen receptor-beta expression, colonocyte proliferation (expressed as PCNA positivity) and apoptosis were evaluated.ResultsIn adenomatous tissue, a significant reduction of oestrogen receptor-beta was observed compared to normal mucosa (10.1 ± 5.5% vs. 44.2 ± 13.7; p < 0.03), while the expression of oestrogen receptor-alpha remained unvaried. Cell proliferative activity significantly increased in adenomatous tissue compared to normal mucosa (59.3 ± 7.1 vs. 18.5 ± 8.8; p < 0.0001), doubling the PCNA/apoptosis ratio. An inverse correlation was found between oestrogen receptor-beta and PCNA expression in adenomas (r = −0.81), a datum confirmed by confocal microscopy evaluation.ConclusionsOur data demonstrate, for the first time, a significant reduction of oestrogen receptor-beta expression already in the pre-cancerous phase of colon carcinogenesis. This suggests a role of selective oestrogen receptor-beta agonists in the prevention of colorectal cancer.